Reverse Medical Corporation has raised $14 million in a Series B private equity financing. New investors Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical Partners were joined by existing investors. The company, which was founded in 2007, makes devices to treat and prevent acute ischemic strokes in patients who have few remaining treatment options. CEO Jeffrey Valko says in a statement that financing will allow Reverse to continue its progress toward worldwide commercialization and profitability. Reverse release